UnknownNot Applicable

Cervical Length in Cases of Placenta Previa

80 participantsStarted 2018-03-01

Plain-language summary

This study establishes the relationship between cervical length and whether it can be used to predict haemorrhage and preterm delivery in cases of placenta previa.

Who can participate

Age range

25 Years – 40 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age: 20-45 years old
. Single Pregnancy
. Fetal gestational age 28 to \< 36 weeks
. Normal amniotic fluid index (AFI)
. Diagnosis of placenta previa by pelvic ultrasound that was confirmed when the lower placental edge overlies the internal cervical os on transvaginal ultrasound (TVS).

Exclusion criteria

. Threatened preterm labor and maternal use of vaginal progesterone.
. Preterm premature rupture of membranes;
. Polyhydramnios;
. Presence of cercelage and history of cervical cone biopsy which both affect cervical length.
. Diagnosis of multiple fetal anomalies;
. Women with other risk factors for intra-partum hemorrhage

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Cervical length measured in mm in relation to antepartum haemorrhage

Timeframe: 4 months

Trial details

NCT IDNCT03451136

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-07-01

Contact for this trial

Marwa Mohamed Eid, PhD

01001225079 Marwameid2014@gmail.com

View on ClinicalTrials.gov More Placenta Previa trials